RNAi and Stabilizer Therapies Drive ATTR-CM Market Growth

добавлена новая статья Health

2025-06-23 12:16:44

The Transthyretin Amyloid Cardiomyopathy (ATTR-CM) market is experiencing transformative growth, led by next-generation therapeutics, increasing diagnosis rates, and strong regulatory momentum. Once considered underdiagnosed and undertreated, ATTR-CM is now at the center of groundbreaking drug innovations that are expanding access and improving outcomes. To Get Free Sample Report:...

0 Комментарии 0 Поделились 275 Просмотры 0 предпросмотр